本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lineage Cell Therapeutics Inc

1.01
-0.0100-0.98%
盤前1.020.0087+0.86%08:02 EDT
成交量:91.34萬
成交額:92.49萬
市值:2.55億
市盈率:-5.44
高:1.03
開:1.02
低:1.00
收:1.02
52周最高:2.09
52周最低:1.00
股本:2.53億
流通股本:1.91億
量比:0.86
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.1855
每股收益(LYR):-0.2761
淨資產收益率:-60.06%
總資產收益率:-17.04%
市淨率:4.19
市盈率(LYR):-3.66

資料載入中...

2019/08/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/08

重要事件披露

Current report, items 2.02 and 9.01
2019/07/30

重要事件披露

Current report, items 5.02 and 5.07
2019/07/05

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/05

重要事件披露

Current report, item 5.02
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/02

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/22

持股變動聲明

Initial statement of beneficial ownership of securities
2019/05/22

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/10

重要事件披露

Current report, items 5.08 and 8.01
2019/05/09

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/05/09

重要事件披露

Current report, items 2.02 and 9.01
2019/05/02

重要事件披露

Current report, items 8.01 and 9.01